Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Other Non-Current Assets of $12.0 million for Q4 2025, little changed year-over-year from $12.0 million in Q4 2024, and little changed quarter-over-quarter from $12.0 million in Q4 2024.
Curaleaf Holdings (CURLF) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $12.0 million for Q4 2025.
- In Q4 2025, Other Non-Current Assets changed 0.0% year-over-year to $12.0 million; the TTM figure through Dec 2025 stood at $12.0 million (changed 0.0% YoY), while the FY2025 annual figure was $12.0 million, changed 0.0% from the prior year.
- Other Non-Current Assets for Q4 2025 stood at $12.0 million, roughly flat from $12.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $17.7 billion in Q1 2022, with the low at -$34.3 million in Q3 2022.
- The 5-year median for Other Non-Current Assets is $17.6 million (2022), against an average of $1.4 billion.
- Peak annual rise in Other Non-Current Assets reached 57395.28% in 2022, while the deepest fall reached 249.85% in 2022.
- Curaleaf Holdings' Other Non-Current Assets stood at $24.3 million in 2021, then sank by 36.27% to $15.5 million in 2022, then slumped by 44.37% to $8.6 million in 2023, then jumped by 39.53% to $12.0 million in 2024, then changed by 0.0% to $12.0 million in 2025.
- Business Quant data shows CURLF's Other Non-Current Assets at $12.0 million in Q4 2025, $12.0 million in Q4 2024, and $8.6 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | 18.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 18.38 Mn |
| Dec 31, 2025 | 12.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Dec 31, 2023 | 8.60 Mn |
| Sep 30, 2023 | 11.18 Mn |
| Jun 30, 2023 | 46.79 Mn |
| Dec 31, 2022 | 15.46 Mn |
| Sep 30, 2022 | -34.28 Mn |
| Jun 30, 2022 | 17.61 Mn |
| Mar 31, 2022 | 17.67 Bn |
| Dec 31, 2021 | 24.26 Mn |
| Sep 30, 2021 | 22.88 Mn |
| Jun 30, 2021 | 45.21 Mn |
| Mar 31, 2021 | 30.73 Mn |
| Dec 31, 2020 | 132.23 Mn |
| Sep 30, 2020 | 34.34 Mn |
| Dec 31, 2019 | 8.83 Mn |
| Sep 30, 2019 | -20.09 Mn |